Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capture of LEO 90100 medication usage with digital tracker and evaluation of efficacy in patients with psoriasis
2017-004508-23Phase 2Terminated
- Sponsor
- LEO Pharma
- Start
- Dec 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of calcipotriol in plaque psoriasis, sponsored by LEO Pharma. Primary endpoint: Patient adherence based on tracker measurements. Started Dec 2017; status: terminated.
02
Drugs
calcipotriol
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2017-004508-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004508-23.